Histological Effects of Pharmacologically Active Human Bile Acid nano/micro-particles in Type-1 Diabetes

References

• Mooranian A , NegruljR , ArfusoF , Al-SalamiH. Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: formulation characterization and effects on production of insulin and inflammation in a pancreatic beta-cell line. Artif. Cells Nanomed. Biotechnol.44(7), 1642–1653 (2016).
   PubMed Web of Science ®Google Scholar
• Negrulj R , MooranianA , Chen-TanNet al. Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes. Artif. Cells Nanomed. Biotechnol.44(5), 1290–1297 (2016).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , MathavanSet al. An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations. Pharm. Dev. Technol.20(6), 702–709 (2015).
   PubMed Web of Science ®Google Scholar
• Armin Mooranian RN , SangeethaMathavan , JorgeMartinezet al. A complex microencapsulated system: a platform for optimised oral delivery of antidiabetic drug-bile acid formulations. Pharm. Dev. Technol. (2014) ( in press).
   Web of Science ®Google Scholar
• Mooranian A , NegruljR , MathavanSet al. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J. Pharm. Innov.9(2), 150–157 (2014).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , Chen-TanNet al. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study. Drug Des. Devel. Ther.8, 1003–1012 (2014).
   PubMed Web of Science ®Google Scholar
• Negrulj R , MooranianA , Al-SalamiH. Potentials and limitations of bile acids in Type 2 diabetes mellitus: applications of microencapsulation as a novel oral delivery system. J. Endocrinol. Diabetes Mellit.1(2), 49–59 (2013).
   Google Scholar
• Adrian TE , GariballaS , ParekhKAet al. Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers. Diabetologia55(9), 2343–2347 (2012).
   PubMed Web of Science ®Google Scholar
• Wu T , BoundMJ , StandfieldSDet al. Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans. Diabetes Obes. Metab.15(5), 474–477 (2013).
   PubMed Web of Science ®Google Scholar
• Mathavan S , Chen-TanN , ArfusoF , Al-SalamiH. Morphological, stability, and hypoglycemic effects of new gliclazide-bile acid microcapsules for Type 1 diabetes treatment: the microencapsulation of anti-diabetics using a microcapsule-stabilizing bile acid. AAPS PharmSciTech19(7), 3009–3018 (2018).
   PubMed Web of Science ®Google Scholar
• Mathavan S , MikovM , Golocorbin-KonS , Al-SalamiH. Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects. Eur. J. Pharm. Sci.106, 1–9 (2017).
   PubMed Web of Science ®Google Scholar
• Mathavan S , Chen-TanN , ArfusoF , Al-SalamiH. The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in Type 1 diabetes. Artif. Cells Nanomed. Biotechnol.44(6), 1508–1519 (2016).
   PubMed Web of Science ®Google Scholar
• Mathavan S , Chen-TanN , ArfusoF , Al-SalamiH. A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes. Drug Deliv.23(8), 2869–2880 (2016).
   PubMed Web of Science ®Google Scholar
• Mooranian A , ZamaniN , TakechiRet al. Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes. Artif. Cells Nanomed. Biotechnol.46(Suppl. 3), S748–S754 (2018).
   PubMedGoogle Scholar
• Mooranian A , NegruljR , Al-SalamiH. Alginate-deoxycholic acid interaction and its impact on pancreatic B-cells and insulin secretion and potential treatment of Type 1 diabetes. J. Pharm. Innov.11(2), 156–161 (2016).
   Web of Science ®Google Scholar
• Mooranian A , NegruljR , MikovM , Golocorbin-KonS , ArfusoF , Al-SalamiH. Novel chenodeoxycholic acid–sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study. J. Microencapsul.32(6), 589–597 (2015).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , Chen-TanNet al. Novel multicompartmental bile acid-based microcapsules for pancreatic beta-cell transPLANTATION. Transplantation99(11), S151–S152 (2015).
   PubMed Web of Science ®Google Scholar
• Mooraniana A , NegruljaR , Chen-TanbNet al. Novel artificial cell microencapsulation of a complex gliclazide–deoxycholic bile acid formulation: a characterisation study. Drug Des. Devel. Ther. (2014) ( in press).
   Web of Science ®Google Scholar
• Mooranian A , NegruljR , Al-SallamiHSet al. Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetes. AAPS PharmSciTech16(1), 45–52 (2015).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , Al-SalamiH. The incorporation of water-soluble gel matrix into bile acid-based microcapsules for the delivery of viable beta-cells of the pancreas, in diabetes treatment: biocompatibility and functionality studies. Drug Deliv. Transl. Res.6(1), 17–23 (2016).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , Al-SalamiH. Flow vibration-doubled concentric system coupled with low ratio amine to produce bile acid-macrocapsules of beta-cells. Ther. Deliv.7(3), 171–178 (2016).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , Al-SalamiH. The impact of allylamine–bile acid combinations on cell delivery microcapsules in diabetes. J. Microencapsul.33(6), 569–574 (2016).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , MathavanSet al. An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations. Pharm. Dev. Technol.20(6), 702–709 (2015).
   PubMed Web of Science ®Google Scholar
• Mooranian A , TakechiR , JamiesonE , MorahanG , Al-SalamiH. The effect of molecular weights of microencapsulating polymers on viability of mouse-cloned pancreatic beta-cells: biomaterials, osmotic forces and potential applications in diabetes treatment. Pharm. Dev. Technol.23(2), 145–150 (2018).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , TakechiR , MamoJC , Al-SallamiH , Al-SalamiH. The biological effects of the hypolipidaemic drug probucol incorporated into bile acid-microcapsules and fed daily for 4-weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects. Drug Deliv. Transl. Res. In press (2018).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , TakechiR , JamiesonE , MorahanG , Al-SalamiH. Alginate-combined cholic acid increased insulin secretion of microencapsulated mouse cloned pancreatic beta cells. Ther. Deliv.8(10), 833–842 (2017).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , TakechiR , MamoJ , Al-SallamiH , Al-SalamiH. The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects. Drug Deliv. Transl. Res.8(3), 543–551 (2018).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , TakechiR , JamiesonE , MorahanG , Al-SalamiH. Electrokinetic potential-stabilization by bile acid-microencapsulating formulation of pancreatic beta-cells cultured in high ratio poly-L-ornithine-gel hydrogel colloidal dispersion: applications in cell-biomaterials, tissue engineering and biotechnological applications. Artif. Cells Nanomed. Biotechnol.46(6), 1156–1162 (2018).
   PubMed Web of Science ®Google Scholar
• Mamo JC , LamV , Al-SalamiHet al. Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration. Ther. Deliv.9(10), 703–709 (2018).
   PubMed Web of Science ®Google Scholar
• Mooranian A , TackechiR , JamiesonE , MorahanG , Al-SalamiH. Innovative microcapsules for pancreatic beta-cells harvested from mature double-transgenic mice: cell imaging, viability, induced glucose-stimulated insulin measurements and proinflammatory cytokines analysis. Pharm. Res.34(6), 1217–1223 (2017).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , TakechiR , JamiesonE , MorahanG , Al-SalamiH. New biotechnological microencapsulating methodology utilizing individualized gradient-screened jet laminar flow techniques for pancreatic beta-cell delivery: bile acids support cell energy-generating mechanisms. Mol. Pharm.14(8), 2711–2718 (2017).
   PubMedGoogle Scholar
• Woodhams L , Al-SalamiH. The roles of bile acids and applications of microencapsulation technology in treating Type 1 diabetes mellitus. Ther. Deliv.8(6), 401–409 (2017).
   PubMedGoogle Scholar
• Al-Salami H , ButtG , TuckerIet al. Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats. Eur. J. Drug Metab. Pharmacokinet.34(1), 43–50 (2009).
   PubMed Web of Science ®Google Scholar
• Al-Salami H , ButtG , TuckerI , MikovM. Influence of the semisynthetic bile acid (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats. Pharmacol. Rep.60(4), 532–541 (2008).
   PubMed Web of Science ®Google Scholar
• Mikov M , BoniNS , Al-SalamiHet al. Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate, in healthy and diabetic rats. Eur. J. Drug Metab. Pharmacokinet.32(1), 7–12 (2007).
   PubMed Web of Science ®Google Scholar
• Mikov M , BoniNS , Al-SalamiH , KuhajdaK , KevresanS , FawcettJP. Pharmacokinetics and hypoglycaemic effect of 3 alpha, 7 alpha-dihydroxy-12-oxo-5beta-cholanate (MKC) in diabetic rat. FEBS J.273, 210–210 (2006).
   Web of Science ®Google Scholar
• Schaumberg DA , GlynnRJ , JenkinsAJet al. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation111(19), 2446–2453 (2005).
   PubMed Web of Science ®Google Scholar
• Akbarzadeh A , NorouzianD , MehrabiMRet al. Induction of diabetes by Streptozotocin in rats. Indian J. Clin. Biochem.22(2), 60–64 (2007).
   PubMedGoogle Scholar
• Aljofan M , RiethmacherD. Anticancer activity of metformin: a systematic review of the literature. Future Sci. OA.5(8), FSO410 (2019).
   PubMed Web of Science ®Google Scholar
• Batts KP , JorgensenRA , DicksonER , LindorKD. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis. Am. J. Gastroenterol.91(11), 2314–2317 (1996).
   PubMed Web of Science ®Google Scholar
• Devaraj S , CheungAT , JialalIet al. Evidence of increased inflammation and microcirculatory abnormalities in patients with Type 1 diabetes and their role in microvascular complications. Diabetes56(11), 2790–2796 (2007).
   PubMed Web of Science ®Google Scholar
• Eizirik DL , ColliML , OrtisF. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol.5(4), 219–226 (2009).
   PubMed Web of Science ®Google Scholar
• Ye L , LiL , WanBet al. Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus. Stem Cell Res. Ther.8(1), 90 (2017).
   PubMedGoogle Scholar
• Karumuthil-Melethil S , SofiMH , GudiR , JohnsonBM , PerezN , VasuC. TLR2- and Dectin 1-associated innate immune response modulates T-cell response to pancreatic beta-cell antigen and prevents type 1 diabetes. Diabetes64(4), 1341–1357 (2015).
   PubMed Web of Science ®Google Scholar
• Cavallo MG , FavaD , MonetiniL , BaroneF , PozzilliP. Cell-mediated immune response to beta casein in recent-onset insulin-dependent diabetes: implications for disease pathogenesis. Lancet348(9032), 926–928 (1996).
   PubMed Web of Science ®Google Scholar
• Devaraj S , GlaserN , GriffenS , Wang-PolagrutoJ , MiguelinoE , JialalI. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes55(3), 774–779 (2006).
   PubMed Web of Science ®Google Scholar
• Higai K , AzumaY , AokiY , MatsumotoK. Altered glycosylation of alpha1-acid glycoprotein in patients with inflammation and diabetes mellitus. Clin. Chim. Acta329(1-2), 117–125 (2003).
   PubMed Web of Science ®Google Scholar
• Kullmann F , GrossV , RuschoffJet al. Effect of ursodeoxycholic acid on the inflammatory activity of indomethacin-induced intestinal inflammation in rats. Z. Gastroenterol.35(3), 171–178 (1997).
   PubMed Web of Science ®Google Scholar
• Martinez-Moya P , Romero-CalvoI , RequenaPet al. Dose-dependent antiinflammatory effect of ursodeoxycholic acid in experimental colitis. Int. Immunopharmacol.15(2), 372–380 (2013).
   PubMed Web of Science ®Google Scholar
• Rakel A , RenierG , RoussinA , BuithieuJ , MamputuJC , SerriO. Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes. Diabetes Obes. Metab.9(1), 127–129 (2007).
   PubMed Web of Science ®Google Scholar
• Mooranian A , NegruljR , ArfusoF , Al-SalamiH. The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study. Drug Deliv. Transl. Res.5(5), 511–522 (2015).
   PubMed Web of Science ®Google Scholar
• Kobayashi M , IkegamiH , FujisawaTet al. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. Diabetes56(1), 239–247 (2007).
   PubMed Web of Science ®Google Scholar
• Staels B , KuipersF. Bile acid sequestrants and the treatment of Type 2 diabetes mellitus. Drugs67(10), 1383–1392 (2007).
   PubMed Web of Science ®Google Scholar
• Houten SM , WatanabeM , AuwerxJ. Endocrine functions of bile acids. EMBO J.25(7), 1419–1425 (2006).
   PubMed Web of Science ®Google Scholar
• Roesch LF , LorcaGL , CasellaGet al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J.3(5), 536–548 (2009).
   PubMed Web of Science ®Google Scholar
• Meadows R . Gut bacteria may override genetic protections against diabetes. PLoS Biol.9(12), e1001215 (2011).
   PubMedGoogle Scholar
• Zelcer N , SaekiT , BotI , KuilA , BorstP. Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter. Biochem. J.369(Pt 1), 23–30 (2003).
   PubMedGoogle Scholar
• Al-Salami H , ButtG , TuckerI , SkrbicR , Golocorbin-KonS , MikovM. Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats. Arch. Drug Inf.1(1), 35–41 (2008).
   PubMedGoogle Scholar
• Al-Salami H , ButtG , FawcettJP , TuckerIG , Golocorbin-KonS , MikovM. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. Eur. J. Drug Metab. Pharmacokinet.33(2), 101–106 (2008).
   PubMed Web of Science ®Google Scholar
• Al-Salami H , ButtG , TuckerIG , MikovM. The influence of pre-treatment with probiotics on the in vitro ileal permeation of the antidiabetic drug gliclazide, in healthy and diabetic rats. Drug Metab. Rev.40(1), 81–82 (2008).
   Google Scholar
• Thomson AB . Unidirectional flux rate of cholesterol and fatty acids into the intestine of rats with drug-induced diabetes mellitus: effect of variations in the effective resistance of the unstirred water layer and the bile acid micelle. J. Lipid Res.21(6), 687–698 (1980).
   PubMed Web of Science ®Google Scholar
• Siow Y , SchurrA , VitaleGC. Diabetes-induced bile acid composition changes in rat bile determined by high performance liquid chromatography. Life Sci.49(18), 1301–1308 (1991).
   PubMed Web of Science ®Google Scholar
• Nervi FO , SeverinCH , ValdiviesoVD. Bile acid pool changes and regulation of cholate synthesis in experimental diabetes. Biochim. Biophys. Acta529(2), 212–223 (1978).
   PubMedGoogle Scholar
• Chen L , YaoX , YoungAet al. Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes. Am. J. Physiol. Endocrinol. Metab.302(1), E68–76 (2012).
   PubMed Web of Science ®Google Scholar
• Vasovic V , VukmirovicS , PosaM , MikovM , RaskovicA , JakovljevicV. Effect of rat pretreatment with aqueous solutions of stevioside and bile acids on the action of certain cardioactive drugs. Eur. J. Drug Metab. Pharmacokinet.31(4), 311–314 (2006).
   PubMed Web of Science ®Google Scholar
• Thomson ABR . Uptake of bile-acids into rat intestine – effect of diabetes-mellitus. Diabetes32(10), 900–907 (1983).
   PubMed Web of Science ®Google Scholar
• Meinders AE , VanBerge Henegouwen GP , WillekensFL , SchwerzelAL , RubenA , HuybregtsAW. Biliary lipid and bile acid composition in insulin-dependent diabetes mellitus. Arguments for increased intestinal bacterial bile acid degradation. Dig. Dis. Sci.26(5), 402–408 (1981).
   PubMed Web of Science ®Google Scholar
• Li-Weber M , KrammerPH. Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat. Rev. Immunol.3(7), 534–543 (2003).
   PubMed Web of Science ®Google Scholar
• Luzina IG , KeeganAD , HellerNM , RookGA , Shea-DonohueT , AtamasSP. Regulation of inflammation by interleukin-4: a review of “alternatives”. J. Leukoc. Biol.92(4), 753–764 (2012).
   PubMed Web of Science ®Google Scholar